Vestal Point Capital »

Monopar Therapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.6M 65k 54.79

More positions owned by Vestal Point Capital

Revolution Medicines (RVMD)
BioMarin Pharmaceutical (BMRN)
Abivax SA Sponsored Ads (ABVX)
Neurocrine Biosciences (NBIX)
Arrowhead Pharmaceuticals (ARWR)
Enliven Therapeutics (ELVN)
Repligen Corporation (RGEN)
Bicara Therapeutics (BCAX)
Nurix Therapeutics (NRIX)
Apogee Therapeutics (APGE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Immunocore Holdings Ads (IMCR)
Taysha Gene Therapies Com Shs (TSHA)
Dyne Therapeutics (DYN)
Sanofi SA Sponsored Adr (SNY)

View all positions for Vestal Point Capital

Top funds holding Monopar Therapeutics

Henderson Group
RA Capital Management
Adage Capital Partners GP
Saturn V Capital Management
Deerfield Management Company
BlackRock
Vanguard Group
ADAR1 Capital Management
Wellington Management Company
Vanguard Capital Management
Siren
Balyasny Asset Management
TCG Crossover Management
Polar Capital Holdings
Alyeska Investment Group

View all funds holding Monopar Therapeutics